A survey of etiological mechanisms and therapy of preterm labor

References

• Rush RW, Keirse MJ, Howat P, Baum JD, Anderson AB, Turnbull AC. Contribution of preterm delivery to perinatal mortality. BMJ 1976; 2: 956–68.
   Google Scholar
• Finnish Perinatal Statistics. National Research and Development Centre for Welfare and Health, STAKES, 1995.
   Google Scholar
• Creasy PK. Preterm birth prevention: where are we? Am J Obstet Gynecol 1993; 168: 1223–30.
   PubMed Web of Science ®Google Scholar
• Romero R, Supelveda W, Baumann P et al. The preterm labor syndrome: biochemical, cytologic, immunologic, pathologic, microbiologic, and clinical evidence that preterm labor is a heterogenous disease. Am J Obstet Gynecol 1993; 168: 288.
   Google Scholar
• Kurki T, Ylikorkala O. Prevention of preterm birth. Fetal and Maternal Medicine Review 1993; 5: 191–202.
   Google Scholar
• Keirse MJNC. New perspectives for the effective treatment of preterm labor. Am J Obstet Gynecol 1995; 173: 618–28.
   PubMed Web of Science ®Google Scholar
• Hakala T. Obstetric care, pregnancy risk factors and perinatal outcome in the province of Uusimaa, Finland, in 1980–81. [Dissertation]. University of Helsinki, 1987.
   Google Scholar
• Hartikainen-Sorri A-L, Sorri M. Occupational and sociomedical factors in preterm birth. Obstet Gynecol 1989; 74: 13–16.
   Google Scholar
• Hakala T, Ylikorkala O. Effective prenatal care decreases the incidence of low birth weight. Am J Perinatol 1989; 6: 222–5.
   Google Scholar
• Soneck JD, Iams JD, Blumenfeld M, Johnson F, Landon M, Gabbe S. Measurement of cervical length in pregnancy: comparison between vaginal ultrasonography and digital examination. Obstet Gynecol 1990; 76: 172–5.
   Google Scholar
• Anderson HF, Nugent CE, Wanty SD, Hayaski RH. Prediction of risk for delivery by ultrasonographic measurement of cervical length. Am J Obstet Gynecol 1990; 163: 859–67.
   PubMed Web of Science ®Google Scholar
• Iams JD, Goldenberg RL, Meis PJ et al. The length of the cervix and the risk of spontaneous preterm delivery. N Engl J Med 1996; 334: 567–72.
   PubMed Web of Science ®Google Scholar
• Kushnir O, Izquierdo LA, Smith JF, Blankstein J, Curet LB. Transvaginal sonographic measurement of cervical length: evaluation of twin pregnancies. J Reprod Med 1995; 40: 380–2.
   Google Scholar
• Goldenberg RL, Iams JD, Miodovnik M et al. The preterm prediction study: risk factors in twin gestations. Am J Obstet Gynecol 1996; 175: 1047–53.
   PubMed Web of Science ®Google Scholar
• Lockwood C, Seneyel A, Dische M et al. Fetal fibronectin in cervical and vaginal secretions as a predictor of preterm delivery. N Engl J Med 1991; 325: 669–74.
   PubMed Web of Science ®Google Scholar
• Nageotte M, Casal D, Senyei A. Fetal fibronectin in patients at increased risk for preterm birth. Am J Obstet Gynecol 1994; 170: 20–5.
   Google Scholar
• Amuller G, Riva A. Morphology and functions of the human seminal vesicle. Andrologia 1992; 24: 183–96.
   Google Scholar
• Kurki T, Ylikorkala O. Coitus during pregnancy is not related to bacterial vaginosis or preterm birth. Am J Obstet Gynecol 1993; 169: 1130–4.
   Google Scholar
• Inglis SR, Jeremias J, Kuno K et al. Detection of tumor necrosis factor-alpha, interleukin-6, and fetal fibronectin in the lower genital tract during pregnancy: relation to outcome. Am J Obstet Gynecol 1994; 171: 5–10.
   PubMed Web of Science ®Google Scholar
• Rizzo G, Capponi A, Rinaldo D, Arduini D, Tedeschi D, Romanini C. Interleukin-6 (IL-6) concentrations in cervical secretions identify intra-amniotic infection in patients with preterm labor (pTl). Am J Obstet Gynecol 1996; 175: 812–17.
   Google Scholar
• Wolfe CD, Patel SP, Linton A et al. Plasma corticotrophin-releasing factor (CRF) in abnormal pregnancy. Br J Obstet Gynaecol 1988; 95: 1003–6.
   PubMedGoogle Scholar
• Kurki T, Laatikainen T, Salminen-Lappalainen K, Ylikorkala O. Maternal plasma corticotrophin-releasing hormone – elevated in preterm labour but unaffected by indomethacin ornylidrin. Br J Obstet Gynaecol 1991; 98: 685–91.
   Google Scholar
• Quartero HWP, Noort WA, Fry CH, Keirse MJNC. Role of prostaglandins and leukotrienes in the synergistic effect of oxytocin and corticotropin-releasing hormone (CRF) on the contraction force in human gestational myometrium. Prostaglandins 1991; 42: 137–50.
   PubMedGoogle Scholar
• Challis JR, Mitchell MD. Basic mechanism of pre-term labour. Res Clin Forums 1994; 16: 39–58.
   Google Scholar
• Berkowitz GS, Lapinski RH, Lockwood CH, Florio P, Blackmore-Prince C, Petraglia F Corticotropin-releasing factor and its binding-protein: maternal serum levels in term deliveries. Am J Obstet Gynecol 1996; 174: 1477–83.
   PubMedGoogle Scholar
• Romero R, Mazor M. Infection and preterm labor. Clin Obstet Gynecol 1988; 31: 553–82.
   PubMed Web of Science ®Google Scholar
• Gibbs RS, Romero R, Hillier SL, Eschenbach DA, Sweet RL. A review of premature birth and subclinical infection. Am J Obstet Gynecol 1992; 166: 1515–28.
   PubMed Web of Science ®Google Scholar
• McGregor JA, French JI, Jones W et al. Bacterial vaginosis is associated with prematurity and vaginal fluid mucinase and sialidase: Results of a controlled trial of topical clindamycin cream. Am J Obstet Gynecol 1994; 170: 1048–60.
   PubMed Web of Science ®Google Scholar
• Regan JA, Chao S, James LS. Premature rupture of membranes, preterm delivery, and group B streptococcal colonization of mothers. Am J Obstet Gynecol 1981; 141: 1846.
   Google Scholar
• Amstey MS, Steadman KT. Symptomatic gonorrhoea and pregnancy. J Am Vener Dis Assoc 1976; 3: 14–16.
   PubMedGoogle Scholar
• Martin DH, Koutsky L, Eschenbach DA et al. Prematurity and perinatal mortality in pregnancies complicated by maternal Chlamydia trachomatis infection JAMA 1982; 247: 1585–8.
   Google Scholar
• Gravett MG, Nelson HP, DeRouen T, Critchlow C, Eschenbach DA, Holmes KK. Independent association of bacterial vaginosis and Chlamydia trachomatis infection with adverse pregnancy outcome. JAMA 1986; 256: 1899–903.
   PubMed Web of Science ®Google Scholar
• Hillier SL, Krohn MA, Cassen E, Easterling TR, Rabe LK, Eschenbach DA. The role of bacterial vaginosis and vaginal bacteria in amniotic fluid in women in preterm labor with intact fetal membranes. Clin Infect Dis 1995; 20: 2768.
   Google Scholar
• Gardner HL, Dukes CD. Haemophilus vaginalis vaginitis. A newly defined specific infection previously classified ‘nonspecific vaginitis’. Am J Obstet Gynecol 1955; 69: 962–76.
   Google Scholar
• Hillier SL. Diagnostic microbiology of bacterial vaginosis. Am J Obstet Gynecol 1993; 169: 455–9.
   PubMed Web of Science ®Google Scholar
• Kurki T, Sivonen A, Renkonen O-V, Savia E, Ylikorkala O. Bacterial vaginosis and pregnancy outcome. Obstet Gynecol 1992; 80: 173–7.
   Google Scholar
• Hay PE, Lamont RF, Taylor-Robinson D, Morgan J, Ison C, Pearson J. Abnormal bacterial colonisation of the genital tract and subsequent preterm delivery and late miscarriage. BMJ 1994; 308: 295–8.
   Google Scholar
• Hillier SL, Nugent RP, Eschenbach DA et al. Association between bacterial vaginosis and preterm delivery of a low-birth-weight infant. N Engl J Med 1995; 333: 1737–42.
   PubMed Web of Science ®Google Scholar
• Kurki T, Hallman M, Zilliacus R, Teramo K, Ylikorkala O. Premature rupture of the membranes: effect of penicillin prophylaxis and long-term outcome of the children. Am J Perinatol 1992; 9; 11–16.
   Google Scholar
• Kirschbaum T. Antibiotics in the treatment of preterm labor. Am J Obstet Gynecol 1993; 168: 1239–46.
   Google Scholar
• Mercer BM, Arheart KL. Antimicrobial therapy in expectant management of preterm premature rupture of membranes. Lancet 1995; 346: 1271–9.
   PubMed Web of Science ®Google Scholar
• Romero R, Sibai B, Caritis S et al. Antibiotic treatment of preterm labor with intact membranes: a multicenter, randomized, double-blinded, placebo-controlled trial. Am J Obstet Gynecol 1993; 169: 764–74.
   PubMed Web of Science ®Google Scholar
• Morales WJ, Schorr S, Albritton J. Effect of metronidatzole in patients with preterm birth in preceding pregnancy and bacterial vaginosis: a placebo-controlled, double-blind study. Am J Obstet Gynecol 1994; 171: 345–9.
   Google Scholar
• McGregor JA, French JI, Parker R et al. Prevention of premature birth by screening and treatment for common genital tract infections: results of a prospective controlled evaluation. Am J Obstet Gynecol 1995; 173: 157–67.
   PubMed Web of Science ®Google Scholar
• Hauth JC, Goldenberg rL, Andrews WW DuBard MB, Copper RL. Reduced incidence of preterm delivery with metronidatzole and erythromycin in women with bacterial vaginosis. N Engl J Med 1995; 333: 1732–6.
   Google Scholar
• Joesoef MR, Hillier SL, Wiknjosastro G et al. Intravaginal clindamycin treatment for bacterial vaginosis: effects of preterm delivery and low birth weight. Am J Obstet Gynecol 1995; 173: 1527–37.
   PubMed Web of Science ®Google Scholar
• Oleen-Burkey MA, Hillier SL. Pregnancy complications associated with bacterial vaginosis and their estimated costs. Infect Dis Obstet Gynecol 1995; 3: 145–7.
   Google Scholar
• Bloom B, Lee DW Costs of preventing preterm birth. N Engl J Med 1996; 331: 1338.
   Google Scholar
• Kekki M, Kurki T, Pelkonen J, Kurkinen-Raty M, Cacciatore B, Paavonen J. Bacterial vaginosis in pregnancy is associated with increased infectious morbidity – a randomized placebo-controlled intervention trial with vaginal clindamycin. Acta Obstet Gynecol Scand Suppl 1997; 76: 28.
   Google Scholar
• Castrén O, Gummerus M, Saarikoski S. Treatment of imminent premature labour. A comparison between the effects of nylidrin chloride and isosupride chloride as well as ethanol. Acta Obstet Gynecol Scand 1975; 54: 95–100.
   Web of Science ®Google Scholar
• Merkatz IR, Peter JB, Barden TP. Ritodrine hydrochloride: a betamimetic for use in preterm labor. II. Evidence of efficacy. Obstet Gynecol 1980; 56: 7–12.
   Google Scholar
• Zuckerman R, Reiss U, Rubinstein I. Inhibition of human premature labor by indomethacin. Obstet Gynecol 1974; 44: 787–92.
   Google Scholar
• Morales WJ, Smith SG, Angel JL, O’Brien WF, Knuppel RA. Efficacy and safety of indomethacin versus ritodrine in the management of preterm labor: a randomized study. Obstet Gynecol 1989; 74: 567–72.
   Google Scholar
• Kurki T, Eronen M, Lumme R, Ylikorkala O. A randomized double-dummy comparison between indometh-acin and nylidrin in threatened preterm labor. Obstet Gynecol 1991; 78: 1093–7.
   PubMed Web of Science ®Google Scholar
• Eronen M, Pesonen E, Kurki T, Ylikorkala O, Hallman M. The effects of indomethacin and a β-sympathomimetic agent on the fetal ductus arteriosus during treatment of premature labor: a randomized double-blind study. Am J Obstet Gynecol 1991; 164: 141–6.
   Google Scholar
• Eronen M, Pesonen E, Kurki T, Teramo K, Ylikorkala O, Hallman M. Increased incidence of bronchopulmonary dysplasia after antenatal administration of indomethacin to prevent preterm labor. J Pediatr 1994; 124: 782–8.
   PubMed Web of Science ®Google Scholar
• Canadian Preterm Labor Investigation Group. Treatment of preterm labor with the beta-adrenergic agonist ritodrine. N Engl J Med 1992; 327: 308–12.
   PubMed Web of Science ®Google Scholar
• Carlan SJ, O’Brien WF, O’Leary TD, Mastogiannis D. Randomized comparative trial of indomethacin and sulindac for the treatment of refractory preterm labor. Obstet Gynecol 1992; 79: 223–8.
   PubMed Web of Science ®Google Scholar
• Rasanen J, Jouppila P Fetal cardiac function and ductus arteriosus during indomethacin and sulindac therapy for threatened preterm labor: a randomized study. Am J Obstet Gynecol 1995; 173: 20–5.
   PubMed Web of Science ®Google Scholar
• Fuchs AR, Fuchs F, Husslein P Soloff MS, Fernström MJ. Oxytocin receptors and human parturition: a dual role for oxytocin in the initiation of labor. Science 1982; 215: 139–68.
   Google Scholar
• Akerlund M, Stromberg P, Hauksson A et al. Inhibition of uterine contractions of premature labour with an oxytocin analogue. Results from a pilot study. Br J Obstet Gynaecol 1987; 94: 1040–4.
   PubMed Web of Science ®Google Scholar
• Goodwin TM, Paul R, Silver H et al. The effect of the oxytocin antagonist atosiban on preterm uterine activity in the human. Am J Obstet Gynecol 1994; 170: 474–8.
   PubMed Web of Science ®Google Scholar
• Moncada S, Higgs A. Mechanism of disease; the L-arginine nitric oxide pathway. N Engl J Med 1993; 329: 1602–7.
   Google Scholar
• Lees C, Campbell S, Jauniaux E et al. Arrest of preterm labour and prolongation of gestation with glyceryl trinitrate, a nitric oxide donor. Lancet 1994; 343: 1325–6.
   PubMed Web of Science ®Google Scholar
• Romero R, Sepulveda W, Mazor M et al. The natural interleukin-1 receptor antagonist in term and preterm parturition. Am J Obstet Gynecol 1992; 167: 863–72.
   PubMed Web of Science ®Google Scholar
• Bry K, Hallman M. Transforming growth factor-ß2 prevents preterm delivery induced by interleukin-1a and tumor necrosis factor-a in the rabbit. Am J Obstet Gynecol 1993; 168: 1318–22.
   PubMed Web of Science ®Google Scholar